Dr Dalila Iannotta
Researcher biography
Dr. Dalila Iannotta obtained her PhD in Cellular and Molecular Biotechnology in 2022. Her goal is to contribute to nanomedicine by developing new delivery systems that decrease side effects and increase the therapeutic activity of medicines.
She has over eight years of research experience in various areas, such as extracellular vesicles, synthetic nanoparticles, and disease models (wounds and neurological conditions). Her research has resulted in nine publications, including in journals such as the Nature Nanotechnology (IF: 38.1), Journal of Extracellular Vesicles (IF: 21.22) and Nano Today (IF: 18.96).
She has mentored 16 Master's degree students and five undergraduate students at various institutions, including at The University of Queensland (Australia), Mayo Clinic (USA) (ranked best hospital in the world, Newsweek), D'Annunzio University of Chieti–Pescara (Italy), and University of L'Aquila (Italy). She has also taken an active role in the "Young Scientists" program for high school students.
Main research fields:
- Hybrid delivery systems: design new hybrid nanosystems consisting of synthetic nanoparticles and extracellular vesicles for a best-of-both worlds approach that enables delivery of therapeutic peptides.
- Advanced purification methods for extracellular vesicles: develop improved purification methods for extracellular vesicles derived from biofluids, such as plasma.